相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Conventional transarterial chemoembolisation in combination with sorafenib for patients with hepatocellular carcinoma: a pilot study
Wolfgang Sieghart et al.
EUROPEAN RADIOLOGY (2012)
Dynamic Contrast-Enhanced Computed Tomography Imaging Biomarkers Correlated With Immunohistochemistry for Monitoring the Effects of Sorafenib on Experimental Prostate Carcinomas
Clemens C. Cyran et al.
INVESTIGATIVE RADIOLOGY (2012)
Phase II study of concurrent transarterial chemoembolization and sorafenib in patients with unresectable hepatocellular carcinoma
Joong-Won Park et al.
JOURNAL OF HEPATOLOGY (2012)
Transarterial Chemoembolization Plus Sorafenib: A Sequential Therapeutic Scheme for HCV-Related Intermediate-Stage Hepatocellular Carcinoma: A Randomized Clinical Trial
Domenico Sansonno et al.
ONCOLOGIST (2012)
Effects of Sorafenib on Intra-Tumoral Interstitial Fluid Pressure and Circulating Biomarkers in Patients with Refractory Sarcomas (NCI Protocol 6948)
Chandrajit P. Raut et al.
PLOS ONE (2012)
The combination of sorafenib with transarterial chemoembolisation for hepatocellular carcinoma
R. Cabrera et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2011)
V-CLIP: Integrating Plasma Vascular Endothelial Growth Factor Into a New Scoring System to Stratify Patients With Advanced Hepatocellular Carcinoma for Clinical Trials
Ahmed O. Kaseb et al.
CANCER (2011)
Phase III study of sorafenib after transarterial chemoembolisation in Japanese and Korean patients with unresectable hepatocellular carcinoma
Masatoshi Kudo et al.
EUROPEAN JOURNAL OF CANCER (2011)
Management of Hepatocellular Carcinoma: An Update
Jordi Bruix et al.
HEPATOLOGY (2011)
Phase II Trial of Sorafenib Combined With Concurrent Transarterial Chemoembolization With Drug-Eluting Beads for Hepatocellular Carcinoma
Timothy M. Pawlik et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Therapeutic Equivalence in Survival for Hepatic Arterial Chemoembolization and Yttrium 90 Microsphere Treatments in Unresectable Hepatocellular Carcinoma A Two-Cohort Study
Brian I. Carr et al.
CANCER (2010)
Design and rationale for the non-interventional Global Investigation of therapeutic DEcisions in hepatocellular carcinoma and Of its treatment with sorafeNib (GIDEON) study
R. Lencioni et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2010)
Sorafenib (SOR) or placebo (PL) in combination with transarterial chemoembolization (TACE) for intermediate-stage hepatocellular carcinoma (SPACE)
R. Lencioni et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial
Ann-Lii Cheng et al.
LANCET ONCOLOGY (2009)
Increased expression of vascular endothelial growth factor in hepatocellular carcinoma after transcatheter arterial chemoembolization
B. Wang et al.
ACTA RADIOLOGICA (2008)
Sorafenib in advanced hepatocellular carcinoma
Josep M. Llovet et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Sorafenib (BAY 43-9006) inhibits tumor growth and vascularization and induces tumor apoptosis and hypoxia in RCC xenograft models
Yong S. Chang et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2007)
Hepatocellular cancer: A guide for the internist
Sameer Parikh et al.
AMERICAN JOURNAL OF MEDICINE (2007)
BAY 43-9006 inhibition of oncogenic RET mutants
F Carlomagno et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2006)
Updated treatment approach to hepatocellular carcinoma
JM Llovet
JOURNAL OF GASTROENTEROLOGY (2005)
Prospective randomized controlled study of interferon-alpha in preventing hepatocellular carcinoma recurrence after medical ablation therapy for primary tumors
SM Lin et al.
CANCER (2004)
Radiofrequency ablation improves prognosis compared with ethanol injection for hepatocellular carcinoma ≤4cm
SM Lin et al.
GASTROENTEROLOGY (2004)
Small hepatocellular carcinoma in cirrhosis: Randomized comparison of radio-frequency thermal ablation versus percutaneous ethanol injection
RA Lencioni et al.
RADIOLOGY (2003)
Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival
JM Llovet et al.
HEPATOLOGY (2003)
BAY 43-9006: Preclinical data
S Wilhelm et al.
CURRENT PHARMACEUTICAL DESIGN (2002)
Effects of long-term postoperative interferon-α therapy on intrahepatic recurrence after resection of hepatitis C virus-related hepatocellular carcinoma -: A randomized, controlled trial
S Kubo et al.
ANNALS OF INTERNAL MEDICINE (2001)
Randomized control trials on chemoembolization for hepatocellular carcinoma - Is there room for new studies?
F Trevisani et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2001)
Liver transplantation for small hepatocellular carcinoma in cirrhosis: Analysis of our experience
E Regalia et al.
TRANSPLANTATION PROCEEDINGS (2001)
New guidelines to evaluate the response to treatment in solid tumors
F Duffaud et al.
BULLETIN DU CANCER (2000)
Angiogenesis in cancer and other diseases
P Carmeliet et al.
NATURE (2000)
Adoptive immunotherapy to lower postsurgical recurrence rates of hepatocellular carcinoma: a randomised trial
T Takayama et al.
LANCET (2000)
New guidelines to evaluate the response to treatment in solid Tumors
P Therasse et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2000)
分享论文
